A prospective, observational study of frailty, quality of life and dialysis in older people with advanced chronic kidney disease.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
16 10 2023
Historique:
received: 18 04 2023
accepted: 29 09 2023
medline: 23 10 2023
pubmed: 17 10 2023
entrez: 16 10 2023
Statut: epublish

Résumé

Frailty is prevalent in older people with chronic kidney disease (CKD) and robust evidence supporting the benefit of dialysis in this setting is lacking. We aimed to measure frailty and quality of life (QOL) longitudinally in older people with advanced CKD and assess the impact of dialysis initiation on frailty, QOL and mortality. Outpatients aged ≥65 with an eGFR ≤ 20ml/minute/1.73m Ninety-eight participants were enrolled. Between enrolment and follow-up, 36% of participants commenced dialysis and 59% died. Frailty prevalence increased from 47% at baseline to 86% at follow-up (change in median FI = 0.22, p < 0.001). Initiating dialysis was not significantly associated with change in FI. QOL declined from baseline to follow-up (mean EQ-5D-5L visual analogue score of 70 vs 63, p = 0.034), though commencing dialysis was associated with less decline in QOL. Each 0.1 increment in baseline FI was associated with 59% increased mortality hazard (HR = 1.59, 95%CI = 1.20 to 2.12, p = 0.001), and commencing dialysis was associated with 59% reduction in mortality hazard (HR = 0.41, 95%CI = 0.20 to 0.87, p = 0.020) irrespective of baseline FI. Frailty increased substantially over four years, and higher baseline frailty was associated with greater mortality. Commencing dialysis did not affect the trajectory of FI but positively influenced the trajectory of QOL from baseline to follow-up. Within the limitations of small sample size, our data suggests that frail participants received similar survival benefit from dialysis as non-frail participants.

Sections du résumé

BACKGROUND
Frailty is prevalent in older people with chronic kidney disease (CKD) and robust evidence supporting the benefit of dialysis in this setting is lacking. We aimed to measure frailty and quality of life (QOL) longitudinally in older people with advanced CKD and assess the impact of dialysis initiation on frailty, QOL and mortality.
METHODS
Outpatients aged ≥65 with an eGFR ≤ 20ml/minute/1.73m
RESULTS
Ninety-eight participants were enrolled. Between enrolment and follow-up, 36% of participants commenced dialysis and 59% died. Frailty prevalence increased from 47% at baseline to 86% at follow-up (change in median FI = 0.22, p < 0.001). Initiating dialysis was not significantly associated with change in FI. QOL declined from baseline to follow-up (mean EQ-5D-5L visual analogue score of 70 vs 63, p = 0.034), though commencing dialysis was associated with less decline in QOL. Each 0.1 increment in baseline FI was associated with 59% increased mortality hazard (HR = 1.59, 95%CI = 1.20 to 2.12, p = 0.001), and commencing dialysis was associated with 59% reduction in mortality hazard (HR = 0.41, 95%CI = 0.20 to 0.87, p = 0.020) irrespective of baseline FI.
CONCLUSIONS
Frailty increased substantially over four years, and higher baseline frailty was associated with greater mortality. Commencing dialysis did not affect the trajectory of FI but positively influenced the trajectory of QOL from baseline to follow-up. Within the limitations of small sample size, our data suggests that frail participants received similar survival benefit from dialysis as non-frail participants.

Identifiants

pubmed: 37845618
doi: 10.1186/s12877-023-04365-4
pii: 10.1186/s12877-023-04365-4
pmc: PMC10580596
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

664

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Clin Interv Aging. 2013;8:797-807
pubmed: 23847412
Stat Med. 2000 Nov 30;19(22):3109-25
pubmed: 11113946
Nephrol Dial Transplant. 2021 Jul 23;36(8):1418-1433
pubmed: 32535622
Intern Med J. 2023 Apr;53(4):465-472
pubmed: 35353436
Nephron Clin Pract. 2014;128(1-2):73-8
pubmed: 25378358
BMC Nephrol. 2020 Aug 31;21(1):377
pubmed: 32867718
J Frailty Aging. 2016;5(3):174-9
pubmed: 29240319
Health Qual Life Outcomes. 2009 May 29;7:48
pubmed: 19476656
Clin Kidney J. 2019 Apr 30;13(1):85-94
pubmed: 32083613
BMC Geriatr. 2021 Dec 18;21(1):719
pubmed: 34922490
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Am J Nephrol. 2013;37(3):231-8
pubmed: 23467046
Nephrology (Carlton). 2021 Jul;26(7):613-622
pubmed: 33715269
Int Urol Nephrol. 2020 Feb;52(2):363-370
pubmed: 31975149
Can J Kidney Health Dis. 2020 May 02;7:2054358120917780
pubmed: 32426148
Australas J Ageing. 2015 Sep;34(3):E9-12
pubmed: 26337415
BMC Med. 2013 Mar 11;11:65
pubmed: 23497404
Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):43-54
pubmed: 33213186
BMC Nephrol. 2021 Sep 11;22(1):307
pubmed: 34507554
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
J Gerontol A Biol Sci Med Sci. 2011 Nov;66(11):1238-43
pubmed: 21852286
Qual Life Res. 1996 Apr;5(2):195-204
pubmed: 8998488
Clin Kidney J. 2018 Apr;11(2):236-245
pubmed: 29644065
Health Qual Life Outcomes. 2016 Sep 20;14(1):133
pubmed: 27644755
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
J Am Med Dir Assoc. 2021 Mar;22(3):535-543.e7
pubmed: 33218914
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Australas J Ageing. 2015 Dec;34(4):247-51
pubmed: 26038150
BMC Nephrol. 2019 Mar 29;20(1):108
pubmed: 30922246
Value Health. 2011 Mar-Apr;14(2):390-9
pubmed: 21402307
Clin J Am Soc Nephrol. 2012 Dec;7(12):2002-9
pubmed: 22956262
Clin Kidney J. 2016 Apr;9(2):324-9
pubmed: 26985387
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1624-1639
pubmed: 27342598
Nephrol Dial Transplant. 2016 Nov;31(suppl 2):ii1-ii66
pubmed: 27807144
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1100-1108
pubmed: 28576906
Kidney Int. 2012 Aug;82(3):261-9
pubmed: 22089945
Thorax. 2016 Jun;71(6):493-500
pubmed: 27030578
Age Ageing. 2016 May;45(3):353-60
pubmed: 26944937
BMC Geriatr. 2016 Nov 21;16(1):188
pubmed: 27871235
Arch Gerontol Geriatr. 2017 Jan - Feb;68:135-142
pubmed: 27810661
J Am Geriatr Soc. 2021 Apr;69(4):1057-1062
pubmed: 33377190
BMC Geriatr. 2015 Mar 18;15:27
pubmed: 25887105
PLoS One. 2016 Nov 10;11(11):e0165675
pubmed: 27832126
CMAJ Open. 2020 Dec 1;8(4):E796-E809
pubmed: 33262118

Auteurs

Shannon J King (SJ)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia. shannon.king@health.wa.gov.au.
Western Australian Country Health Service, Busselton Health Campus, West Busselton, WA, 6280, Australia. shannon.king@health.wa.gov.au.

Natasha Reid (N)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.

Sarah J Brown (SJ)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
Cairns and Hinterland Hospital and Health Service, Brisbane City, QLD, Australia.

Lucinda J Brodie (LJ)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.

Aaron D H Sia (ADH)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
Department of Kidney and Transplantations Services, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.

Mark D Chatfield (MD)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.

Ross S Francis (RS)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
Department of Kidney and Transplantations Services, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.

Nancye M Peel (NM)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.

Emily H Gordon (EH)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
Department of Geriatric Medicine, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.

Ruth E Hubbard (RE)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, St Lucia, QLD, Australia.
Department of Geriatric Medicine, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH